• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

celiac disease

Metallic arrow symbols which are illuminated by blue and magenta lights merge on blue and magenta b
Biotech

Barinthus enters reverse merger with metabolic disease biotech

The merged entity will work to advance Clywedog’s diabetes portfolio plus Barinthus’ immunology and immunology program.
Gabrielle Masson Sep 30, 2025 10:39am
Healthy foods surrounding chalk drawing of gut

Edited T cells allow gluten-sensitive mice to eat grains

Mar 20, 2025 7:16am
bowel

GI-focused CRO boosts trial tech with adaptive software

Feb 3, 2025 11:40am
An arrow incrementally going up stairs before pointing straight up Blue background

Topas says celiac candidate shines but keeps data under wraps

Oct 15, 2024 8:08am
layoffs cut staff reduction workforce

Barinthus lays off 25%, sidelines prostate cancer program

Jun 13, 2024 5:30am
reshuffle pipeline target reorganize shift change

Equillium swaps subcutaneous cytokine inhibitor for oral option

Dec 21, 2023 10:58am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings